This article gives a comprehensive overview of multiple myeloma (MM), a complex blood cancer involving overproduction of plasma cells. Although MM remains incurable, patients are living longer as a result of multiple treatment options. However, MM patients are also living with a higher symptom burden. The overall aims in managing MM are therefore to control disease progression, prolong survival and improve quality of life
Priya Sriskandarajah, Faith E Davies Divisions of Molecular Pathology, Cancer Therapeutics, and Clin...
Multiple myeloma is an oncological disease of plasma cells which causes bone pain, anemia and kidney...
CITATION: Fazel, F. & Bassa, F. An approach to the diagnosis and management of multiple myeloma. Sou...
Multiple myeloma is a cancer of the red bone marrow and despite modern treatments, such as high dose...
Multiple myeloma (MM) is a hematological malignancy caused by the clonal expansion of plasma cells. ...
Multiple myeloma (MM) is a B-cell malignancy of the plasma cell and represents the second most commo...
Multiple myeloma is a cancer formed by malignant plasma cells. Normal plasma cells are found in the ...
Multiple myeloma (MM) is a malignancy characterized by an accumulation of plasma cells / plasma blas...
Multiple myeloma is a malignant disease characterized by plasmacytosis, paraprotein production, bone...
Myeloma is a challenging blood cancer characterized by bone destruction, hypercalcaemia, renal insuf...
There is a broad spectrum of diseases labeled as multiple myeloma (MM). This is due not only to the ...
Multiple myeloma, also known as plasma cell myeloma is the most important subgroup amongst the plasm...
Multiple myeloma is the second most common haematological malignancy in high-income countries, and t...
Multiple myeloma (MM) is an incurable hematologic malignancy that mainly affects elderly individuals...
Multiple myeloma (MM) is a hematological malignancy arising from differentiated B-lymphocyte white b...
Priya Sriskandarajah, Faith E Davies Divisions of Molecular Pathology, Cancer Therapeutics, and Clin...
Multiple myeloma is an oncological disease of plasma cells which causes bone pain, anemia and kidney...
CITATION: Fazel, F. & Bassa, F. An approach to the diagnosis and management of multiple myeloma. Sou...
Multiple myeloma is a cancer of the red bone marrow and despite modern treatments, such as high dose...
Multiple myeloma (MM) is a hematological malignancy caused by the clonal expansion of plasma cells. ...
Multiple myeloma (MM) is a B-cell malignancy of the plasma cell and represents the second most commo...
Multiple myeloma is a cancer formed by malignant plasma cells. Normal plasma cells are found in the ...
Multiple myeloma (MM) is a malignancy characterized by an accumulation of plasma cells / plasma blas...
Multiple myeloma is a malignant disease characterized by plasmacytosis, paraprotein production, bone...
Myeloma is a challenging blood cancer characterized by bone destruction, hypercalcaemia, renal insuf...
There is a broad spectrum of diseases labeled as multiple myeloma (MM). This is due not only to the ...
Multiple myeloma, also known as plasma cell myeloma is the most important subgroup amongst the plasm...
Multiple myeloma is the second most common haematological malignancy in high-income countries, and t...
Multiple myeloma (MM) is an incurable hematologic malignancy that mainly affects elderly individuals...
Multiple myeloma (MM) is a hematological malignancy arising from differentiated B-lymphocyte white b...
Priya Sriskandarajah, Faith E Davies Divisions of Molecular Pathology, Cancer Therapeutics, and Clin...
Multiple myeloma is an oncological disease of plasma cells which causes bone pain, anemia and kidney...
CITATION: Fazel, F. & Bassa, F. An approach to the diagnosis and management of multiple myeloma. Sou...